Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.
Mr. Christopher Simon es el President de Haemonetics Corp, se unió a la empresa desde 2016.
¿Qué tal es el rendimiento del precio de la acción HAE?
El precio actual de HAE es de $0, ha disminuido un 100% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Haemonetics Corp?
Haemonetics Corp pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Haemonetics Corp?
La capitalización bursátil actual de Haemonetics Corp es $NaN
¿Es Haemonetics Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 11 analistas han realizado calificaciones de análisis para Haemonetics Corp, incluyendo 4 fuerte compra, 6 compra, 5 mantener, 0 venta, y 4 fuerte venta